A hybrid approach to re-engineer a SARS-CoV-1 neutralizing antibody against SARS-CoV-2

FHS
August 21, 2023
11:47 am

A hybrid approach involving a combination of conventional discovery and antibody repurposing to combat COVID-19.

Optimal BP After Stroke; Psilocybin for Depression

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

September 10, 2023

ChatGPT doesn’t know much about drugs, Hims & Hers enters weight-loss market

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in

December 5, 2023

Flawed Rules in No Surprises Act Hurt Doctors and Patients, Experts Say

The No Surprises Act has led to unintended consequences for physician practices that could ultimately hurt patients, said physicians and patient advocates during a hearing

September 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.